Provenzano lab engineered immune cells to fight malignant tumors.
July 25, 2021
The study shows how engineered immune cells used in new cancer therapies can overcome physical barriers to allow a patient’s own immune system to fight tumors. “This study is our first publication where we have identified some structural and signaling elements where we can tune these T cells to make them more effective cancer fighters,” said Provenzano. Read more.